The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Popova E.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Davydovskaya M.V.

Research and Practical Centre for Clinical Investigations and Evaluation of Medical Technologies, Moscow Health Department, Moscow, Russia

Demina T.L.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta

Kukel' T.M.

Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza i kafedra nevrologii i neĭrokhirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova;
Okruzhnoe nevrologicheskoe otdelenie GP #180 Severo-Zapadnogo administrativnogo okruga Moskvy

Lashch N.Iu.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta

Popova N.F.

kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta;
gorodskaia klinicheskaia bol'nitsa #11

Khachanova N.V.

Burdenko Neurosurgical Institute, Moscow, Russia

Shchur S.G.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta

Gusev E.I.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

The first experience of the use the Russian -interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis

Authors:

Popova E.V., Boĭko A.N., Davydovskaya M.V., Demina T.L., Kukel' T.M., Lashch N.Iu., Popova N.F., Khachanova N.V., Shchur S.G., Gusev E.I.

More about the authors

Read: 6722 times


To cite this article:

Popova EV, Boĭko AN, Davydovskaya MV, et al. . The first experience of the use the Russian -interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(10‑2):93‑96.

Recommended articles:
Biobanking in clinical trials invo­lving multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):7-15
Adhe­rence to treatment in the mana­gement of patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):26-32
Modern pathogenetic treatment of rare demye­linating diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):33-36
Opti­mal patient profile for ofatumumab treatment: analysis of Russian data from the Phase 3 study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):37-42
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Features of primary forms of headache in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73
Neurofilament light chain: a diagnostic pote­ntial for multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):115-119

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.